DL-2-Methylglutamic acid is a glutamic acid derivative in which a methyl substituent is introduced at the 2-position of the side chain, yielding a branched, non-proteinogenic amino acid framework with an α-amino group and a carboxyl group. The molecule contains an additional side-chain carboxylic acid characteristic of glutamate-like amino acids, and the "DL" designation indicates a racemic mixture of stereoisomers at the stereogenic center(s) implied by the substituted glutamate skeleton. As a structurally modified amino acid, it is used as a substrate or building block in peptide and amino acid derivative synthesis, and as a chemical probe for structure-activity and labeling studies where altered steric and electronic properties relative to unmodified glutamic acid are of interest.
CAT No: CP08301
DL-2-Methylglutamic acid is a glutamic acid derivative in which a methyl substituent is introduced at the 2-position, generating a sterically modified amino acid scaffold with two carboxylic acid functionalities and one additional stereogenic element within the side-chain region. The molecule contains a primary amino group and carboxyl groups that can be selectively protected or converted into activated derivatives, enabling controlled peptide coupling and downstream transformations. The DL designation indicates a racemic mixture at the stereocenter(s), which is relevant for studies requiring stereochemical comparison, racemate-based library synthesis, or later resolution strategies. The presence of multiple acidic groups and the steric influence of the 2-methyl substituent shape its reactivity profile, making it suitable for protected amino acid synthesis, amide formation, and process-oriented intermediate preparation.
1. Peptide Synthesis
DL-2-Methylglutamic acid supports peptide building workflows where glutamate-like side-chain chemistry is required, while the 2-methyl substitution modulates steric access to the side-chain carboxylate. The amino and carboxyl functionalities can be orthogonally protected to enable stepwise N- and side-chain coupling, and the resulting protected amino acid derivative can participate in standard amide bond formation using peptide coupling reagents. Racemic incorporation can be used for generating peptide mixtures for screening, followed by stereochemical refinement when needed. Downstream, the incorporated 2-methylglutamate residue can be used to construct analogs that probe how side-chain branching affects conformational preferences and coupling stability in peptide science.
2. Amino Acid Derivatization
DL-2-Methylglutamic acid can be converted into ester, amide, or activated acid intermediates for chemical derivatization routes that require a multi-functional amino acid core. The two carboxyl groups enable selective transformation strategies, such as forming monoesters for controlled reactivity, generating acid chlorides or anhydrides for subsequent coupling, or preparing protected derivatives for sequential functional group installation. The 2-methyl substituent can influence chemoselectivity and steric outcomes during derivatization, which can be exploited when constructing functionalized amino acid derivatives for synthetic organic chemistry. The resulting intermediates can feed into peptidomimetic scaffolds, polymer-reactive monomers, or biochemical research reagents where glutamate-like functionality is combined with steric tuning.
3. Chiral Resolution Studies
DL-2-Methylglutamic acid is well suited as a chiral starting material for resolution workflows that separate enantiomers after racemate formation or during downstream intermediate preparation. The stereogenic center(s) created by the 2-methyl substitution allow enantiomer-specific behavior in salt formation, derivatization, and chromatographic separation, while the amino and carboxyl groups provide multiple handles for forming diastereomeric derivatives. Protected amino acid strategies can be applied to lock functional groups during resolution, improving handling and enabling later conversion back to coupling-ready forms. The separated enantiomers can then be used for stereochemically defined peptide building blocks and for structure-function studies where side-chain stereochemistry is a key variable.
4. Chemical Biology Probes
DL-2-Methylglutamic acid can be incorporated into chemical biology constructs where glutamate-mimicking geometry and carboxylate presentation are needed for molecular recognition studies. The amino acid's side-chain carboxyl group can be used to generate amide-linked conjugates, while the additional carboxyl functionality supports formation of linkers, chelators, or reactive handles for bioconjugation chemistry. Racemic material may serve in early-stage probe development, with stereochemical refinement applied when binding selectivity depends on absolute configuration. Downstream derivatives derived from this amino acid can function as labeling reagents, affinity tags, or substrate analogs that support biochemical investigations of recognition motifs and enzymatic processing.
5. Pharmaceutical Intermediate Preparation
DL-2-Methylglutamic acid is applicable to pharmaceutical intermediate preparation where amino acid-derived fragments are required for medicinal chemistry and process chemistry routes. The molecule's protected amine and protected carboxyl groups can be transformed into coupling-ready intermediates for generating amide-containing scaffolds, including side-chain substituted analogs that reflect glutamate pharmacophore geometry. The ability to manage multiple acid groups through protection and activation supports scalable synthesis planning, including conversion to mono-protected derivatives for controlled functional group sequencing. Industrially, the compound can serve as a chiral synthetic intermediate precursor to stereodefined analogs, enabling manufacturing of amino acid-based building blocks used in fine chemical synthesis and downstream drug-candidate scaffold elaboration.
6. Polymer Modification
DL-2-Methylglutamic acid can be employed in functional material and polymer modification contexts where amino acid-derived monomers introduce pendant carboxylate and amide-forming functionality. The amino acid core can be converted into protected or activated monomers, enabling incorporation into polymer backbones or side chains through condensation, coupling, or post-polymer modification strategies. The 2-methyl side-chain branching can alter local hydrophilicity, steric interactions, and ion-binding behavior of the resulting polymer, which can be relevant for materials that rely on controlled charge density. Downstream, polymer-bound derivatives can be used to generate ion-responsive materials, chelating polymers, or biodegradable-linker-containing systems, reflecting the broader utility of amino acid chemistry in specialty chemical production.
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.